论文信息 - FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) - 字舞流文

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

J. Guthridge | J. Merrill | J. James | D. Zack | B. Burington | A. Khosroshahi | A. Askanase | F. Koumpouras | M. F. Khan | Wambui Machua | S. Sheikh | G. Rathi | P. Foster | Joshua June